SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001052918-20-000197
Filing Date
2020-08-06
Accepted
2020-08-06 15:25:40
Documents
11
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 AVRICORE HEALTH INC. FORM 6-K avricore6kmar2020.htm 6-K 8806
2 NEWS RELEASE ex99-1.htm EX-99 9904
3 ABRIDGEMENT NOTICE ex99-2.htm EX-99 3266
4 REQUEST FOR FINANCIAL STATEMENTS ex99-3.htm EX-99 5113
5 MANAGEMENT INFORMATION CIRCULAR ex99-4.htm EX-99 248981
6 FORM OF PROXY ex99-5.htm EX-99 929
7 ex991_1.jpg GRAPHIC 4463
8 ex992_1.jpg GRAPHIC 4463
9 ex994_1.jpg GRAPHIC 6545
10 ex995_2.jpg GRAPHIC 534326
11 ex995_1.jpg GRAPHIC 593035
  Complete submission text file 0001052918-20-000197.txt   1851540
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 201081231
SIC: 2834 Pharmaceutical Preparations